Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
america tags : Presentation save search
TG Therapeutics Announces Presentation of Data for BRIUMVI® in Multiple Sclerosis at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual Forum
Published: 2024-03-01 (Crawled : 12:30) - globenewswire.com
TGTX | $13.99 -1.83% -1.86% 2.7M
|
Health Technology
|
| O: 1.86%
H: 4.79%
C: 2.39%
briumvi presentation sclerosis treatment research therapeutics
Apollomics Announces Presentation of Vebreltinib Data at the 2023 IASLC North America Conference on Lung Cancer (NACLC)
Published: 2023-11-28 (Crawled : 12:00) - globenewswire.com
APLM | $0.4548 -4.85% -5.1% 170K
|
n/a
|
| O: -2.63%
H: 6.31%
C: 0.9%
america lung conference presentation cancer
Corbus Pharmaceuticals Data on CRB-601 avβ8 Blocking Antibody Accepted for Presentation at the America Association for Cancer Research Annual Meeting
Published: 2023-03-14 (Crawled : 21:00) - prnewswire.com
CRBP | $35.5 -5.94% -6.37% 220K
|
Health Technology
|
| O: -2.28%
H: 3.67%
C: -3.0%
crb-601 america pharmaceuticals research antibody meeting association presentation cancer
TG Therapeutics Announces Presentation of Data from the ULTIMATE I & II Phase 3 Trials of BRIUMVI™ (ublituximab-xiiy) in Multiple Sclerosis at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual Forum
Published: 2023-02-24 (Crawled : 13:00) - biospace.com/
TGTX | $13.99 -1.83% -1.86% 2.7M
|
Health Technology
|
| O: -2.49%
H: 1.2%
C: -2.12%
treatment trials research therapeutics presentation sclerosis multiple sclerosis
IceCure's ProSense Featured in Poster Presentation at Radiological Society of North America's 2022 Annual Meeting
Published: 2022-11-30 (Crawled : 15:00) - biospace.com/
ICCM | $1.22 0.82% 94K
|
Manufacturing
|
| O: 4.37%
H: 0.0%
C: -2.33%
prosense meeting presentation
Scripps to webcast presentation from Bank of America Securities Leveraged Finance Conference on Nov. 29
Published: 2022-11-21 (Crawled : 17:00) - prnewswire.com
SSP | News | $3.8 0.53% 0.53% 1.2M
|
Consumer Services
|
| O: 0.36%
H: 3.35%
C: 1.28%
america conference presentation
Latest Research Evaluating VASCEPA® (Icosapent Ethyl) to be Presented at the American College of Cardiology’s 71st Annual Scientific SessionAmarin-Supported Research and Analyses to Be Featured in Six Presentations
Published: 2022-03-21 (Crawled : 14:00) - biospace.com/
AMRN | News | $0.8844 0.13% 0.12% 660K
|
Health Technology
|
| O: -0.32%
H: 0.81%
C: -0.65%
vascepa america research cardio presentation cardiology test sap
Biond Biologics Announces Oral Presentation for BND-67, an Inhibitor of CD28 Shedding, a Potential Novel Resistance Mechanism to Anti PD-1 Therapy, at the American Association for Cancer Research (AACR) 2022 Annual Meeting
Published: 2022-03-21 (Crawled : 13:30) - biospace.com/
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: 4.78%
H: 0.0%
C: -5.78%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -0.92%
H: 0.0%
C: 0.0%
bnd-67 america research presentation potential therapy cancer ism
Incyte Announces Multiple Abstracts from its Dermatology Portfolio have been Accepted for Presentation at the 2022 American Academy of Dermatology (AAD) Annual Meeting
Published: 2022-03-18 (Crawled : 15:00) - biospace.com/
INCY | $51.72 0.14% 0.14% 1.5M
|
Health Technology
|
| O: 0.0%
H: 1.39%
C: 1.14%
america derm presentation
ASLAN Pharmaceuticals Announces Acceptance of Late-Breaking Abstract on Eblasakimab Proof-of-Concept Study in Atopic Dermatitis for Oral Presentation at the 2022 American Academy of Dermatology Annual Meeting
Published: 2022-03-18 (Crawled : 12:00) - biospace.com/
ASLN | News | $0.4863 3.69% 3.56% 1M
|
Health Technology
|
| O: 6.42%
H: 0.99%
C: -2.02%
america als atopic dermatitis dermatitis derm presentation roof
Kintara Therapeutics Announces Data Presentation at the 2022 American Association for Cancer Research Annual Meeting
Published: 2022-03-15 (Crawled : 14:30) - biospace.com/
KTRA | $0.1374 3.54% 3.42% 5.8M
|
Distribution Services
|
| O: 0.29%
H: 3.57%
C: 0.65%
america research therapeutics presentation cancer
Vaccinex, Inc. Announces Upcoming Presentation at the 2022 American Association for Cancer Research Meeting Updating the Phase 1b Segment of the KEYNOTE-B84 Study of Pepinemab in Combination with KEYTRUDA (pembrolizumab) in Patients with Recurrent or Meta
Published: 2022-03-09 (Crawled : 16:20) - ir.vaccinex.com
VCNX | $4.9631 -2.76% 3.5K
|
Health Technology
|
| O: 1.83%
H: 18.92%
C: 17.12%
america ema phase 1b research presentation pepinemab phase 1 keytruda dating cancer vaccine phase 2b
Nuvectis Announces Upcoming Oral and Poster Presentations at the 2022 American Association for Cancer Research Meeting
Published: 2022-03-10 (Crawled : 14:00) - globenewswire.com
NVCT | $6.715 1.9% 1.86% 51K
|
|
| O: -4.04%
H: 6.31%
C: 2.23%
america pos research presentation cancer
Vaccinex, Inc. Announces Upcoming Presentation at the 2022 American Association for Cancer Research Meeting Updating the Phase 1b Segment of the KEYNOTE-B84 Study of Pepinemab in Combination with KEYTRUDA (pembrolizumab) in Patients with Recurrent or Metastatic Head and Neck Cancer
Published: 2022-03-09 (Crawled : 23:00) - globenewswire.com
VCNX | $4.9631 -2.76% 3.5K
|
Health Technology
|
| O: 1.83%
H: 18.92%
C: 17.12%
america ema phase 1b research presentation pepinemab phase 1 keytruda dating cancer head and neck vaccine phase 2b
I-Mab Announces Multiple Presentations at the 2022 American Association for Cancer Research (AACR) Annual Meeting
Published: 2022-03-09 (Crawled : 22:00) - biospace.com/
IMAB | $1.805 0.28% 0.28% 110K
|
Health Technology
|
| O: 4.24%
H: 3.69%
C: 2.92%
america research presentation cancer
Arcellx Announces Pre-Clinical Data Presentation for ACLX-002, a Novel CD123-targeted Universal CAR-T Cell Therapy for Relapsed or Refractory Acute Myeloid Leukemia at the American Association for Cancer Research Annual Meeting 2022
Published: 2022-03-08 (Crawled : 23:00) - prnewswire.com
ACLX | $52.795 -3.02% -3.12% 300K
|
|
| O: 2.8%
H: 3.41%
C: -6.98%
aclx-002 america myeloid leukemia car-t leukemia research presentation cel pre-clinical therapy cancer t-cell preclinical acute myeloid leukemia
Adagene Announces Four Poster Presentations on Robust Preclinical Pipeline of Antibody-Based Therapeutics at Upcoming American Association for Cancer Research (AACR) Annual Meeting
Published: 2022-03-08 (Crawled : 23:00) - globenewswire.com
ADAG | $2.65 -2.63% 740
|
Manufacturing
|
| O: 1.25%
H: 8.84%
C: -2.24%
america pos research therapeutics presentation preclinical cancer antibody pre-clinical
Kronos Bio’s Investigational CDK9 Inhibitor KB-0742 to be Featured in Four Preclinical Poster Presentations at American Association for Cancer Research Annual Meeting 2022
Published: 2022-03-08 (Crawled : 22:00) - globenewswire.com
KRON | $0.9644 1.52% 1.49% 880K
|
Health Technology
|
| O: 2.13%
H: 6.85%
C: 6.25%
kb-0742 america pos research presentation preclinical cancer pre-clinical
Olema Oncology Announces Poster Presentations at the American Association for Cancer Research (AACR) Annual Meeting 2022
Published: 2022-03-08 (Crawled : 22:00) - globenewswire.com
OLMA | $10.15 1.5% 1.48% 410K
|
Health Technology
|
| O: 2.97%
H: 10.42%
C: 8.65%
america ema pos research presentation cancer
ORIC Pharmaceuticals Announces Multiple Presentations at the 2022 American Association for Cancer Research (AACR) Annual Meeting
Published: 2022-03-08 (Crawled : 22:00) - globenewswire.com
ORIC | $8.08 -7.87% -8.54% 370K
|
Health Technology
|
| O: 0.43%
H: 13.86%
C: 8.57%
america als research presentation cancer
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.